+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Move Over, Ozempic There Might Be A New Weight Loss Drug is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Move Over, Ozempic There Might Be A New Weight Loss Drug | RobinsPost News & Noticias

'Next Ozempic': A new weight loss drug is on its way, aims to deliver 30% weight loss with fewer side effects


Scientists at Tufts University are developing an experimental drug targeting four hormones—GLP-1, GIP, glucagon, and PYY—to achieve significant weight loss with fewer side effects than current GLP-1 ... Read More

Half Of Ozempic Weight-Loss Users Drop The Drug Within A Year


MONDAY, Sept. 15, 2025 (HealthDay News) — Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says. Read More

Hims & Hers falls 8% as FDA issues warning letter over compounded weight loss drug


The U.S. FDA has issued a warning letter to Hims & Hers Health ( NYSE: HIMS) over its marketing of compounded semaglutide, the weight loss drug marketed under the brand name Wegovy by Novo Nordisk ( ... Read More

Could GLP-1 weight-loss medications like Ozempic become the 'everything drug'?


Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a "weight-inclusive" healthcare company based in Boston, said she would caution against labeling any medication as an "everything ... Read More

Weight loss drugs may be helping Gen Z’s get sober, study finds


73% of patients said weight-loss drugs like Ozempic and Wegovy helped them cut down on substance use. Many reported fewer cravings, slips, and even quitting altogether. Experts believe these ... Read More

Novo Nordisk to sell weight-loss drug for $499 to eligible customers


Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 diabetes patients in the U.S. The company said in March that it was cutting the ... Read More

Can coffee affect Ozempic for weight loss? What the experts say


Ozempic and Coffee: How Do They Interact? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus